FDA clears Onkos Surgical's ELEOS Limb Salvage System: 5 things to know

Written by Megan Wood | November 01, 2016 | Print  |

The FDA cleared Parsippany, N.J.-based Onkos Surgical to market its ELEOS Limb Salvage System.

Here are five things to know:


1. Surgeons may now use ELEOS to treat patients with bone loss caused by cancer, trauma or surgical procedures.


2. The system is designed to offer a surgeon flexibility and modularity when performing these complex cases.


3. ELEOS represents a long-term, reconstructive choice for oncology patients.


4. Patrick Treacy, Onkos Surgical founder and CEO, commented they are expecting a full launch of ELEOS in the first quarter of 2017.


5. Founded in 2015, Onkos Surgical is a privately held surgical oncology company.


More articles on devices:
Dr. Hythem P. Shadid of Genesis Orthopedics creates video highlighting 3-D implants: 3 takeaways
FDA claims 12 US hospitals did not report patient deaths, injuries linked to medical devices in timely manner — 6 things to know 
Zimmer Biomet Q3 net sales up 4%, but lowers growth projections — shares drop 13%: 6 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers